Business Wire

CA-MFA

16.11.2021 15:03:14 CET | Business Wire | Press release

Share
MFA Launches Network Identifier Program for Enterprises to Deploy Their Own Private Network

MFA , an international organization championing the global industry adoption of private networks based upon 3GPP technologies, today announced its Network Identifier Program for enterprises. Enterprises now have access to the MFA’s unique global PLMN ID that they can use when deploying their own private network to ensure that only authorized devices connect to their network. The program reduces complexity and streamlines the network development process for enterprises by eliminating the need for them to separately apply for their own PLMN ID.

“Our mission is to make it as easy as possible for enterprises to quickly deploy their own private network and realize the benefits of greater control over their network, enhanced on-premise data security, and predictable performance,” said Mazen Chmaytelli, president, MFA. “MFA was awarded a unique global PLMN ID by the ITU, and we are creating this new program to ensure all industry verticals have ready access to a PLMN ID that will support their digitalization journey.”

Enterprises and industry verticals including maritime, manufacturing, warehouses, utilities, and venues can select a Private Network ID package or a Neutral Host Network (NHN) ID package that will provide them with all the items they need to deploy a neutral host or private network. For large deployments, enterprises will be able to add-on IDs to meet their requirements for coverage and capacity.

“With access to the global PLMN ID from MFA, network suppliers or operators will have the necessary identifiers to create unique and distinguishable private networks, streamlining the deployment process for their enterprise customers – anywhere in the world they are located,” said Asimakis Kokkos, MFA Technical Specification Group Chair and Head of Technology Ecosystems, Nokia Enterprise Solutions.

New Private Network Subscriber category created to jumpstart deployment
MFA has also created a new Private Network Subscriber category that will grant enterprises one complimentary Private Network ID package that they can use immediately to deploy their own 5G private network in locally licensed spectrum or MulteFire®/4G private network in unlicensed spectrum today.

“For a one-time fee, Private Network Subscribers gain access to a Private Network ID package that is evergreen and does not need to be renewed,” added Chmaytelli. “Our members also will receive complimentary packages that will meet their deployment requirements. The MFA wants to help seed as many private networks as possible, and we’re excited to bring this important program to the entire industry.”

To further enable private network deployments, MFA, a 3GPP Market Representation Partner (MRP), previously announced that it is also developing Uni5G™ Technology Blueprints. These blueprints will provide enterprises with practical guidance on implementing the key features from the 3GPP 5G standards that are relevant to their specific deployment. The first blueprints will be finalized in December 2021.

The Network Identifier program is administered by the MFA Certificate Authority and is available today to MFA members and non-members. For companies interested in joining the program, visit www.mfa-tech.org .

Resources:

About MFA
MFA is an international organization that is championing the global industry adoption of private networks using MFA-defined MulteFire specifications for LTE and Uni5G Technology Blueprints for 5G. With Uni5G or MulteFire, enterprises can efficiently deploy their own optimized, reliable and secure private network in unlicensed, shared or locally licensed spectrum. For more information, visit www.mfa-tech.org .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release

The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u

Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release

Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release

LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The

“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release

Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the

Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release

Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye